Influence of molecular parameters and increasing magnetic field strength on relaxivity of gadolinium- and manganese-based T1 contrast agents - Wikidata - awgldk - TriplyDB

Influence of molecular parameters and increasing magnetic field strength on relaxivity of gadolinium- and manganese-based T1 contrast agents

Influence of molecular parameters and increasing magnetic field strength on relaxivity of gadolinium- and manganese-based T1 contrast agents

http://www.wikidata.org/entity/Q33403791

about

Physicochemical characterization, and relaxometry studies of micro-graphite oxide, graphene nanoplatelets, and nanoribbons Physical Properties of Eu2+-Containing Cryptates as Contrast Agents for Ultrahigh-Field Magnetic Resonance Imaging MRI detection of VEGFR2 in vivo using a low molecular weight peptoid-(Gd)8-dendron for targeting Metalloprotein-based MRI probes Lanthanide probes for bioresponsive imaging Overcoming the concentration-dependence of responsive probes for magnetic resonance imaging Basic MR relaxation mechanisms and contrast agent design Molecular fMRI Design of ProCAs (protein-based Gd(3+) MRI contrast agents) with high dose efficiency and capability for molecular imaging of cancer biomarkers Virus-based nanomaterials as positron emission tomography and magnetic resonance contrast agents: from technology development to translational medicine In Vitro Longitudinal Relaxivity Profile of Gd(ABE-DTTA), an Investigational Magnetic Resonance Imaging Contrast Agent.Protein MRI contrast agent with unprecedented metal selectivity and sensitivity for liver cancer imaging.Amide conjugates of the DO3A-N-(α-amino)propionate ligand: leads for stable, high relaxivity contrast agents for MRI?Gd2O3 nanoparticles: size-dependent nuclear magnetic resonance.Gd(DOTAla): a single amino acid Gd-complex as a modular tool for high relaxivity MR contrast agent development.Is macrocycle a synonym for kinetic inertness in Gd(III) Complexes? Effect of coordinating and noncoordinating substituents on inertness and relaxivity of Gd(III) chelates with DO3A-like ligands.Modulating water-exchange rates of lanthanide(III)-containing polyaminopolycarboxylate-type complexes using polyethylene glycol.Surface modified Eu:GdVO4 nanocrystals for optical and MRI imaging.Self-aggregated dinuclear lanthanide(III) complexes as potential bimodal probes for magnetic resonance and optical imaging.Strategies for optimizing water-exchange rates of lanthanide-based contrast agents for magnetic resonance imaging.Use of contrast agents in oncological imaging: magnetic resonance imaging.Direct measurement of the Mn(II) hydration state in metal complexes and metalloproteins through 17O NMR line widths.Ln[DO3A-N-α-(pyrenebutanamido)propionate] complexes: optimized relaxivity and NIR optical properties.Manganese(III) porphyrins complexed with P22 virus-like particles as T1-enhanced contrast agents for magnetic resonance imaging.Leakage and water exchange characterization of gadofosveset in the myocardium.Gd(DOTAlaP): exploring the boundaries of fast water exchange in gadolinium-based magnetic resonance imaging contrast agents Progesterone-targeted magnetic resonance imaging probes Hexameric Mn(II) dendrimer as MRI contrast agent.Tuning phenols with Intra-Molecular bond Shifted HYdrogens (IM-SHY) as diaCEST MRI contrast agents MR imaging probes: design and applications.High relaxivity Gd(III)-DNA gold nanostars: investigation of shape effects on proton relaxation.A water-soluble and water-coordinated Mn(II) complex: synthesis, characterization and phantom MRI image study.Poly(acrylic acid) Bridged Gadolinium Metal-Organic Framework-Gold Nanoparticle Composites as Contrast Agents for Computed Tomography and Magnetic Resonance Bimodal Imaging.Concentration-independent MRI of pH with a dendrimer-based pH-responsive nanoprobe Gd-DTPA-Dopamine-Bisphytanyl Amphiphile: Synthesis, Characterisation and Relaxation Parameters of the Nanoassemblies and Their Potential as MRI Contrast Agents.Impact of biopolymer matrices on relaxometric properties of contrast agents.Gd(III)-nanodiamond conjugates for MRI contrast enhancement.MRI estimation of gadolinium and albumin effects on water proton.A new ex vivo method to evaluate the performance of candidate MRI contrast agents: a proof-of-concept study.High-relaxivity magnetic resonance imaging contrast agents. Part 2. Optimization of inner- and second-sphere relaxivity

P2860

Q21134550-D495C24E-6B24-431E-B27A-907576AEC717 Q24617694-FA7CAE50-F54E-4B95-9B16-AEB37A0BEB04 Q24619870-8DBD6E34-1150-4F58-AE32-4131816BB437 Q26849668-802C83A7-8B8C-42A8-9447-9977977225C5 Q27000361-DDD32990-2EC5-4B6A-90A0-F450E85C2C6D Q27013727-A3705C38-2936-42BC-AF84-530E9BD16280 Q27692546-CD535EE6-85C4-441A-8A83-E9610818107B Q28075589-8D9912A8-53CA-4218-8E42-3A0BE789981A Q28235682-CC68D33A-7A05-4E86-902D-AF20FCD6640D Q28550482-953219D4-D818-4211-91B9-BB26A1598121 Q30277356-7BAFA6F1-1A43-48BD-AC90-13D85B556317 Q30299954-11B305D5-22DC-4BCF-B234-56BF50FAA182 Q30575277-04C2D22D-8EA9-467B-A078-2FFCBF1AFA0B Q30575279-31CA0374-A12B-4C5C-A5FA-22227250D951 Q30577667-39A3BE25-65DF-4D4A-8232-FF88DC44B5E0 Q30604750-C5603CEE-0E6E-4A4D-B875-1EA9F4D56BF6 Q30616187-96D20957-C761-4BBB-AEB0-7EFEC5338BC9 Q30648773-116FCF24-9130-4B7F-9773-BDCEA17BB053 Q30654757-C728FD6B-5F29-47EC-9D45-26F1AFD0673E Q30660032-3298427F-3D88-49A0-A7BA-0C0C5AC13FB8 Q30669419-00A52283-FE1C-4983-A102-AD77B28D4AE1 Q30671069-C2FF9E5B-5A28-4AC6-A5DB-CCBDF7A8019A Q30716845-B6D7A148-A2B2-4145-9EE6-2D7D7F9FFE4C Q30722696-018F7831-C6C7-46BA-A337-080DA178DFB0 Q30732433-DEE9E1E1-D65D-4D97-830C-9A8C836718A2 Q30830645-D67BCDD9-E3FE-4EC7-8917-CC5FC2FA76BA Q30836342-EF5E533A-20D0-40E4-A8B2-74E9A040D06E Q30851400-71F87AE7-8FD2-4235-9B5A-6F0C8591A434 Q30859038-C750AF1C-0F37-4C4E-A2A8-50562B0AE140 Q30868199-4206044E-E5A8-4D85-BDB8-F1D6C311036E Q30901328-C5FB9798-1F6D-4665-B0D7-2EAAF79FF904 Q30978230-E5453580-4D63-4386-82AC-8A621105E39B Q30978842-D58002FC-1699-4507-8255-D4114FA3D202 Q30980323-CF4B4F39-F265-4502-8E84-B00E9A8C7136 Q30993842-371C2F85-1D63-46E5-9816-362978C72AC6 Q31147094-75F320AE-0B80-4761-902D-BE164DA9B4E5 Q33520972-053A0622-D805-42DD-ABDD-CD529BB8EC3B Q33584465-D35CC910-07EF-43B2-A1AF-5A4BAF4D354B Q33614436-81A3E11A-23E9-4709-81EF-22A121602055 Q33679680-BE29426B-A115-4F5F-BBCE-D2F09E312925

P2860

Influence of molecular parameters and increasing magnetic field strength on relaxivity of gadolinium- and manganese-based T1 contrast agents

http://www.wikidata.org/entity/Q33403791

description

2009 nî lūn-bûn

@nan

2009 թուականի Մարտին հրատարակուած գիտական յօդուած

@hyw

2009 թվականի մարտին հրատարակված գիտական հոդված

@hy

2009年の論文

@ja

2009年論文

@yue

2009年論文

@zh-hant

2009年論文

@zh-hk

2009年論文

@zh-mo

2009年論文

@zh-tw

2009年论文

@wuu

name

Influence of molecular paramet ...... anese-based T1 contrast agents

@ast

Influence of molecular paramet ...... anese-based T1 contrast agents

@en

type

label

Influence of molecular paramet ...... anese-based T1 contrast agents

@ast

Influence of molecular paramet ...... anese-based T1 contrast agents

@en

prefLabel

Influence of molecular paramet ...... anese-based T1 contrast agents

@ast

Influence of molecular paramet ...... anese-based T1 contrast agents

@en

P1433

Q33403791-76E3913E-4394-40ED-B6AF-78C4A94E09DE

P1476

Q33403791-7695E3A9-5D48-4A04-9087-5D83063F7FA6

P2093

Q33403791-2FB60D86-9E6D-4774-B9AF-8B949ED6A6BB

Q33403791-3BC47DA7-CB7B-403A-BFF7-937213D02308

Q33403791-69C1C850-E4FE-4487-9C4E-5502D987B5BA

P2860

Q33403791-01441A77-6422-4D78-BBDC-F245BA4573A0

Q33403791-065750AF-0FD1-4D9D-B15B-B89526AD0E87

Q33403791-0C6B69BD-EEE7-4F51-8C0D-30A8F49190E9

Q33403791-138794A7-3DAA-4E4F-BF65-7996407B9661

Q33403791-23E5B2D1-4EFB-4963-B62E-B9B768952720

Q33403791-2B238D8B-6D46-4DDA-A7B9-5264584F52BE

Q33403791-2BA62A3D-3D55-49F5-BE0B-82C1061D6777

Q33403791-3085C686-1EBD-4CDA-9B2A-5436B5A8DCF6

Q33403791-38C059B1-03CF-4EE6-AED2-05668A76F380

Q33403791-3F9C39CB-A118-4A2D-AC67-F868F1E90ACA

P304

Q33403791-3BF8AF8E-5DA8-4008-B657-871AEEAABEAF

P31

Q33403791-E66214B7-BA43-45AF-8519-84D2618870D9

P356

Q33403791-365CE487-8624-4E7A-A74A-46C0308AF013

P433

Q33403791-B77929FF-E2FE-4F07-9C3A-1880E828CF3A

P478

Q33403791-49DEDF20-D32A-4FC5-B24A-A3329965423D

P50

Q33403791-FDC3E6AA-6428-4682-ACDE-8F931BF6D1CE

P577

Q33403791-D5354DEC-4886-4DA0-ACE1-D0412E1EB8F3

P5875

Q33403791-5837058F-88A3-483D-81A7-7702F5834302

P698

Q33403791-EED2D240-8C75-4568-88E2-33FCB4CCA560

P932

Q33403791-3951B160-3DDC-462A-80E5-92C525FC7CF5

P356

P1433

Contrast Media & Molecular Imaging

P1476

Influence of molecular paramet ...... anese-based T1 contrast agents

@en

P2093

Christian T Farrar

http://www.w3.org/2001/XMLSchema#string

Luca Frullano

http://www.w3.org/2001/XMLSchema#string

Ritika Uppal

http://www.w3.org/2001/XMLSchema#string

P2860

Gadolinium(III) Chelates as MRI Contrast Agents: Structure, Dynamics, and Applications

[GdPCP2A(H(2)O)(2)](-): a paramagnetic contrast agent designed for improved applications in magnetic resonance imaging.

Molecular dynamics simulations of MRI-relevant GdIII chelates: direct access to outer-sphere relaxivity.

Lipari-Szabo approach as a tool for the analysis of macromolecular gadolinium(III)-based MRI contrast agents illustrated by the [Gd(EGTA-BA-(CH2)12)]nn+ polymer.

Physicochemical and biological evaluation of P792, a rapid-clearance blood-pool agent for magnetic resonance imaging.

Displacement of Inner-Sphere Water Molecules from Eu(3+) Analogues of Gd(3+) MRI Contrast Agents by Carbonate and Phosphate Anions: Dissociation Constants from Luminescence Data in the Rapid-Exchange Limit.

The Gd(3+) complex of a fatty acid analogue of DOTP binds to multiple albumin sites with variable water relaxivities.

The interaction of MS-325 with human serum albumin and its effect on proton relaxation rates.

The gadolinium(III)-water hydrogen distance in MRI contrast agents.

Lanthanide(III) complexes of novel mixed carboxylic-phosphorus acid derivatives of diethylenetriamine: a step towards more efficient MRI contrast agents.

P304

89-100

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1002/CMMI.267

http://www.w3.org/2001/XMLSchema#string

P433

2

http://www.w3.org/2001/XMLSchema#string

P478

4

http://www.w3.org/2001/XMLSchema#string

P50

P577

2009-03-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

23957634

http://www.w3.org/2001/XMLSchema#string

P698

19177472

http://www.w3.org/2001/XMLSchema#string

P932

3995751

http://www.w3.org/2001/XMLSchema#string